an experimental experience

https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-treatment-postpartum-depression

+ 82 more

8/4/23 at 10:48pm

Organization

FDA.gov

Author

Office of the Commissioner

Summarize

Health Depression Zurzuvae FDA FDA Approves First Oral Treatment for Postpartum Depression - FDA.gov

The FDA approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.

Create an account or login to join the discussion